Table 1 Data of IBA-1 positive cells density (microglial density) and statistical comparisons between experimental conditions and brain regions of interest (ROI).

From: Dietary linoleic acid supplementation protects against obesity-induced microglial reactivity in mice

ROI

Microglial density (mean n° IBA-1+ cells/mm2 ± SEM)

 

KW—H; post-hoc MWU—Z

Bregma coord. (mm)

STD-VEH

STD-LA

HFD-VEH

HFD-LA

n

STD-VEH vs. STD-LA

STD-VEH vs. HFD-VEH

HFD-VEH vs. HFD-LA

Hypothalamic regions

 PVN

0.26–0.02 aB

213.66 ± 13.20

213.36 ± 10.55

290.38 ± 12.39

214.95 ± 7.58

29

H3,29 = 15.0, p = 0.001

Z = − 0.7, p = 0.49

Z = − 2.8, p = 0.005

Z = 3.1, p = 0.002

 PLH

1.06–1.34 pB

189.07 ± 7.35

195.19 ± 6.21

242.31 ± 6.56

185.32 ± 8.37

28

H3,28 = 15.6, p = 0.001

Z = − 0.7, p = 0.48

Z = − 3.1, p = 0.002

Z = 3.1, p = 0.002

 VMH

1.70–1.94 pB

229.57 ± 10.14

233.21 ± 7.96

306.35 ± 8.78

254.86 ± 6.28

29

H3,29 = 17.5, p = 0.000

Z = − 0.3, p = 0.77

Z = − 3.2, p = 0.002

Z = 2.8, p = 0.005

 LH

2.06–2.30 pB

237.91 ± 5.80

250.47 ± 9.09

325.19 ± 14.85

248.69 ± 11.14

29

H3,29 = 15.8, p = 0.001

Z = − 0.9, p = 0.35

Z = − 3.3, p = 0.001

Z = 3.0 , p = 0.003

 STN

2.06–2.30 pB

309.96 ± 8.83

298.33 ± 15.56

462.10 ± 28.25

309.89 ± 9.37

29

H3,29 = 17.0, p = 0.000

Z = 0.7, p = 0.49

Z = − 3.4, p = 0.001

Z = 3.1, p = 0.002

 PSTN

2.06–2.30 pB

325.71 ± 11.12

337.97 ± 16.49

472.81 ± 13.73

357.33 ± 19.37

27

H3,27 = 16.0, p = 0.001

Z = − 0.5, p = 0.61

Z = − 3.1, p = 0.002

Z = 3.0 , p = 0.003

Cortical areas

 PL

1.94–1.70 aB

235.10 ± 7.68

248.41 ± 5.72

296.24 ± 3.72

235.57 ± 6.37

30

H3,30 = 18.6, p = 0.000

Z = − 1.6, p = 0.11

Z = − 3.4, p = 0.001

Z = 3.2, p = 0.001

 IL

1.94–1.70 aB

225.29 ± 8.75

232.91 ± 3.83

291.88 ± 7.72

230.63 ± 8.34

30

H3,30 = 16.9, p = 0.000

Z = − 0.8, p = 0.42

Z = − 3.3, p = 0.001

Z = 3.2, p = 0.001

 OFC

1.94–1.70 aB

266.86 ± 5.35

259.20 ± 6.35

317.25 ± 4.27

264.50 ± 4.59

30

H3,30 = 18.0, p = 0.000

Z = 1.0, p = 0.30

Z = − 3.4, p = 0.001

Z = 3.2, p = 0.001

 ACC

1.10–0.98 aB

230.62 ± 14.58

250.00 ± 5.32

273.86 ± 6.76

217.20 ± 10.85

28

H3,28 = 11.0, p = 0.011

Z = − 0.9, p = 0.36

Z = − 2.2, p = 0.031

Z = 2.8, p = 0.005

 aIC

0.26–0.02 aB

300.03 ± 9.49

318.94 ± 15.61

351.29 ± 9.81

331.52 ± 7.54

29

H3,29 = 9.1, p = 0.028

Z = − 0.9, p = 0.35

Z = − 2.9, p = 0.003

Z = 1.8, p = 0.07

Subcortical regions

 DMS

1.10–0.98 aB

246.79 ± 8.84

242.62 ± 14.26

288.46 ± 6.47

235.04 ± 9.46

28

H3,28 = 12.3, p = 0.006

Z = 0.3, p = 0.80

Z = − 2.8, p = 0.005

Z = 2.8, p = 0.004

 DLS

1.10–0.98 aB

270.83 ± 12.57

271.98 ± 7.51

315.77 ± 12.57

293.75 ± 13.13

28

H3,28 = 8.0, p = 0.045

Z = − 0.2, p = 0.85

Z = − 2.3, p = 0.024

Z = 0.71, p = 0.48

 dBNST

0.26–0.02 aB

209.70 ± 6.85

204.16 ± 9.42

286.20 ± 6.62

236.54 ± 6.51

29

H3,29 = 20.9, p = 0.000

Z = 0.3, p = 0.73

Z = − 3.4, p = 0.001

Z = 3.1, p = 0.002

 dHipp

1.70–1.94 pB

330.90 ± 11.52

333.75 ± 13.23

419.78 ± 14.34

345.10 ± 5.57

29

H3,29 = 15.6, p = 0.001

Z = − 0.3, p = 0.73

Z = − 3.1, p = 0.002

Z = 2.1, p = 0.04

 LHb

1.70–1.94 pB

291.87 ± 12.86

293.03 ± 7.09

348.31 ± 25.37

286.56 ± 12.69

29

H3,29 = 7.0, p = 0.073

 BLA

1.06–1.34 pB

322.64 ± 14.54

315.45 ± 10.04

416.04 ± 17.94

353.95 ± 15.25

29

H3,29 = 15.6, p = 0.001

Z = 0.8, p = 0.42

Z = − 3.2, p = 0.002

Z = 1.8, p = 0.07

 CeA

1.06–1.34 pB

287.64 ± 17.71

258.29 ± 8.92

373.61 ± 17.62

257.40 ± 17.09

29

H3,29 = 15.7, p = 0.001

Z = 1.5, p = 0.13

Z = − 2.7, p = 0.006

Z = 2.8, p = 0.004

 VPM

2.06–2.30 pB

252.81 ± 7.58

248.19 ± 8.85

342.91 ± 16.00

259.90 ± 4.00

29

H3,29 = 15.8, p = 0.001

Z = 0.6, p = 0.56

Z = − 3.2, p = 0.002

Z = 3.0, p = 0.003

 VPPC

2.06–2.30 pB

239.20 ± 10.60

255.05 ± 9.55

368.39 ± 18.39

264.02 ± 12.21

29

H3,29 = 18.2, p = 0.000

Z = − 1.0, p = 0.32

Z = − 3.4, p = 0.001

Z = 3.1, p = 0.002

  1. Significant values are in bold.
  2. Bregma coordinates (mm) for sections selection: anterior to Bregma—aB; posterior to Bregma—pB. Food regimen: standard diet—ST; high-fat diet—HFD. Treatment: vehicle—VEH; linoleic acid supplementation—LA. Data are means ± SEM. Paraventricular nucleus of the hypothalamus—PVN, peduncular part of the lateral hypothalamus –PLH, ventromedial hypothalamus—VMH, lateral hypothalamus—LH, subthalamic nucleus of the hypothalamus—STN, parasubthalamic nucleus of the hypothalamus—PSTN, prelimbic cortex—PL, infralimbic cortex—IL, orbitofrontal cortex—OFC, anterior cingulate cortex—ACC, anterior insular cortex—aIC, dorsomedial striatum—DMS, dorsolateral striatum—DLS, dorsal region of the bed nucleus of the stria terminalis—dBNST, dorsal hippocampus—dHipp, lateral habenula—LHb, basolateral amygdala—BLA, central amygdala—CeA, ventral posteromedial thalamic nucleus—VPM, and parvicellular part of the ventral posterior thalamic nucleus—VPPC. n: sample size.